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The Charcot foot: a pictorial review
Andrea B. Rosskopf1,2*, Christos Loupatatzis3, Christian W. A. Pfirrmann1,2, Thomas Böni2,4 and
Martin C. Berli2,4
Abstract
Charcot foot refers to an inflammatory pedal disease based on polyneuropathy; the detailed pathomechanism of
the disease is still unclear. Since the most common cause of polyneuropathy in industrialized countries is diabetes
mellitus, the prevalence in this risk group is very high, up to 35%. Patients with Charcot foot typically present in
their fifties or sixties and most of them have had diabetes mellitus for at least 10 years. If left untreated, the disease
leads to massive foot deformation. This review discusses the typical course of Charcot foot disease including
radiographic and MR imaging findings for diagnosis, treatment, and detection of complications.
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Key points
 X-rays may be normal during early stage of Charcot
foot
 MRI should be done with large field of view
covering the entire foot
 MRI can be used for early diagnosis, monitoring of
disease activity and complications
 Acute MRI findings include bone marrow edema,
soft tissue edema, and subchondral fractures
 Chronic MRI findings include subchondral cysts,
joint destructions, joint effusion, and bony
proliferations
Annotation regarding wording of planes of foot
imaging in this review
Hindfoot: sagittal = parallel to long axis of metatarsal
bones; coronal = perpendicular to long axis of metatarsal
bones; axial = perpendicular to long axis of the tibia.
Forefoot: sagittal = parallel to long axis of metatarsal
bones; axial = perpendicular to long axis of metatarsal
bones; coronal = parallel to foot sole.
Introduction
The Charcot foot has been first described in 1868 by
Jean-Martin Charcot, a French pathologist and
neurologist, in patients with tabes dorsalis (myelopathy
due to syphilis) [1]. The detailed pathomechanisms of
this disease still remain unclear: there is consensus
that the cause is multifactorial and that polyneurop-
athy (reduced pain sensation and proprioception) is
the underlying basic condition of this disease. In in-
dustrialized countries, diabetes mellitus is the main
cause of polyneuropathy in the lower limb [2]—much
more common than other causes like alcohol abuse or
malnutrition. The prevalence of Charcot foot in a gen-
eral diabetic population is estimated between 0.1 and
7.5%, but regarding diabetic patients with apparent
peripheral neuropathy, this prevalence is increasing up
to 35% [3]. The risk of getting a Charcot foot is not re-
lated to the type (I or II) of diabetes mellitus. The inci-
dence of bilateral involvement of the feet has been
reported between 9 and 75% [2]. Patients with Char-
cot foot typically present within their fifties or sixties
and most of them have had diabetes mellitus for at
least 10 years [2].
Natural course of disease
Charcot foot is characterized by four different disease
stages (Fig. 1) [7, 8], resembling active and inactive dis-
ease phases: inflammation, fragmentation, coalescence,
consolidation. The disease is normally limited to a sin-
gle-run through these different disease stages. The active
phase is characterized by a hot, red, and swollen foot
(inflammation), often without pain, due to the polyneur-
opathy (Fig. 2) [1]. In the active phase, the bone gets
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fragile due to temporary osteopenia leading to fractures,
joint destructions (often Lisfranc’s joint) and collapse of
the longitudinal arch of the foot [2, 8, 9]. During the less
active or inactive phase, the foot is not red any more,
but some soft tissue and bone marrow edema may last.
Prominent osteophytes and palpable loose bodies are the
consequence of a substantial joint and bone destruction
followed by bony proliferations [2, 9]. The typical end-
stage appearance of a Charcot foot is the so-called
rocker-bottom deformity (Fig. 3).
A recent study showed that there is a risk of re-activa-
tion of a “formerly in-active” Charcot foot in about 23%
within a mean interval of 27 months [4] (Fig. 1).
Clinical stages and differential diagnoses
The (modified) Eichenholtz classification [5, 6], which
relies on clinical and x-ray findings, is frequently used
for clinical assessment of a suspected Charcot foot
(stages 0, I, II, III, IV). Stage 0 is the ideal stage for early
diagnose of a Charcot foot, but also the most difficult
one for the clinician: the patients typically present with a
red, swollen, warm foot, but no visible changes (yet) on
radiographs. Typical differential diagnoses in this early
stage include deep vein thrombosis, gout, osteoarthritis,
and infection (cellulitis/osteomyelitis) [10].
Treatment
Current state-of-the art treatment is the off-loading of
the affected foot—as soon as possible—so that the
Fig. 1 Charcot foot: natural course of disease with recurrence rates
about 23%, adapted from [4–6]
Fig. 2 A typical Charcot foot in acute active phase: red, hot, and
swollen right foot
Fig. 3 Rocker-bottom deformity: end-stage of Charcot foot. a
Clinical image. b Corresponding lateral radiograph
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mentioned four disease stages run-through while the
foot is protected from major shape changes (Fig. 4) [1].
One commonly used method is the treatment of patients
with custom-made removable total contact casts (Fig. 5a)
until the activity signs of the Charcot foot are signifi-
cantly reduced or gone. This might take up to 18 months
[4]. Establishing an early diagnosis and therefore an early
off-loading treatment is crucial for the prognosis and
outcome of an acute Charcot foot. The stabilization with
the Ilizarov external fixator frame is considered an alter-
native treatment option for the off-loading [11] (Fig. 5b)
in feet with complications (severe deformity or after the
removal of osteomyelitic bone fragments) [12].
Imaging findings
This review is focused on typical findings of a Charcot
foot on radiographs and MR imaging since these two
modalities play the most important role for disease mon-
itoring, classification, and treatment [13].
Classifications
The Charcot foot can be classified using various systems
according to anatomical landmarks and clinical symp-
toms. The most common ones are the Sanders and Fryk-
berg classification, the Brodsky classification, and the
Eichenholtz-classification [5, 7, 14–17]. This review
covers the Sanders and Frykberg classification in detail,
because it can be used without additional clinical
information.
Sanders and Frykberg classification
Sanders and Frykberg identified five zones of disease
distribution according to their anatomical location, as
demonstrated in Fig. 6. Most commonly involved are
zone II in about 45% and zone III in about 35% of
cases [2], Fig. 7 and Fig. 8.
Fig. 4 Off-loading therapy with total contact casts give the patient
the chance of healing properly without debilitating deformities and
with a preserved longitudinal arch
Fig. 5 a Removable total contact cast used for off-loading treatment
of active Charcot foot. b Ilizarov fixateur in a patient with
Charcot foot
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Role of conventional radiographs
Conventional radiographs of the Charcot foot are trad-
itionally the standard imaging technique to establish the
diagnosis, to stage, and to monitor the disease. The main
value of plain radiographs is to assess the position of the
bones to each other in general, and in particular under
load (Fig. 9) [13, 18, 19].
Typical measurements on radiographs [19] help to de-
termine the severity of deformation in a Charcot foot
(especially in follow up studies), Fig. 10:
1. Meary’s angle: angle between the line originating
from the center of the body of the talus, bisecting
the talar neck and head, and the line through the
longitudinal axis of 1st metatarsal; normal value
should be around 0°.
2. Cuboid height: perpendicular distance from the
plantar aspect of the cuboid to a line drawn from
the plantar surface of the calcaneal tuberosity to the
plantar aspect of the 5th metatarsal head. Mean
normal value is about 1.2 cm above that line.
3. Calcaneal pitch: angle between a line extending
from the plantar aspect of the calcaneus to the
plantar surface of the 5th metatarsal head and the
line extending from the most plantar portion of the
calcaneal tuberosity to the most plantar portion of
the anterior calcaneus [18]. Normal value lies
between 20 and 30°.
4. Hindfoot-forefoot angle: Dorsoplantar (dp)
radiographs can reliably show the (sub-)luxation in
the Lisfranc’s joint, especially the medial aspect of
the joint (Fig. 11). Dorsoplantar radiographs in
follow-up studies typically show the increase in
forefoot abduction relative to the hindfoot over
time, the so-called hindfoot-forefoot angle (Fig. 11).
Oblique conventional radiographs are superior to
Fig. 6 Anatomical distribution in the Sanders and Frykberg
classification. Zone I: metatarsophalangeal and interphalangeal joints,
zone II: tarsometatarsal joints, zone III: tarsal joints, zone IV: ankle and
subtalar joints, and zone V: calcaneus
Fig. 7 Radiographs of the right foot in dp (a) and lateral projection
(b) involving zone II. Note the involvement of the tarsometatarsal
articulations (white arrows) with lateral subluxation of the metatarsal
bones in the Lisfranc’s joint
Fig. 8 Lateral radiograph of the left foot in a patient with Charcot
foot involving zone III according to Sanders and Frykberg
classification (tarsal joints). The white arrow points at the typical
inferior luxation of the talar head; the red arrow points at the
cuboid, typically becoming the most inferior bone of the foot
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dp-radiographs in visualizing the lateral aspect of
the Lisfranc’s joint (3rd to 5th tarsometatarsal
joint).
Role of magnetic resonance imaging
MRI can be very helpful in order to establish an early diag-
nosis of Charcot foot. MRI also allows to determine the
course of the healing process and the success of the off-
loading treatment (monitoring: active or inactive disease).
Another very significant role of MRI is its ability to further
evaluate complications of a Charcot foot, in particular soft
tissue infections and osteomyelitis (Fig. 12) [3, 13, 20]. In
patients with contraindications for MR examination, nu-
clear medicine imaging can be performed (see section
below: “CTand nuclear medicine imaging”).
MRI-protocol
For Charcot foot, it is essential to use a large field
of view (FoV) since the disease can affect the entire
foot. It is necessary to use a fluid sensitive sequence
(e.g., STIR) for assessing edema in the bone marrow
and soft tissue. A classic T1 TSE (turbo spin-echo)
sequence is irreplaceable to demonstrate the anat-
omy and the fat signal of the bone marrow. T2-
weighted sequences can demonstrate the presence of
subchondral cysts and help to identify fluid collec-
tions and sinus tracts [2, 3]. Axial images are useful
to assess the Lisfranc’s joint disease. An MRI proto-
col proposal for Charcot foot evaluation is demon-
strated in Fig. 13. Nephrotoxic effects of gadolinium
Fig. 9 Weight-bearing radiograph in dp projection (a baseline, b
5 months later). Notice the development of fractures and
subchondral cysts, erosions, joint distention, and luxation of the
Lisfranc’s joint (white arrows)
Fig. 10 Lateral weight-bearing radiographs showing the typical
course of Charcot foot disease over time (a baseline, b 10 months
later). Note the continuous increase of Meary’s angle (black angle),
the diminution of cuboid height, which is becoming negative
(yellow distance) and the decrease of the calcaneal pitch (white
angle) [19]
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are still controversely discussed, and almost all pa-
tients with a Charcot foot are at risk for develop-
ment of renal failure (due to diabetes) [21, 22].
Therefore, the application of contrast media should
be limited to patients with suspected infections (ab-
scess collections and osteomyelitis).
MRI for Charcot foot diagnosis
Charcot foot cannot be diagnosed based on imaging
alone and should always be interpreted in context with
the clinical parameters (known polyneuropathy, red foot,
and so on) [2, 23]. However, there are some typical MR
imaging features for the early- and late-stage of a Char-
cot foot.
MRI for diagnosis of early-stage Charcot foot MRI is
the best imaging modality to confirm diagnosis of sus-
pected early active Charcot disease [24]. This may be cru-
cial, since conventional radiographs can appear normal
during very early stage of Charcot disease (Eichenholtz
stage 0, Fig. 14). Early signs of a Charcot foot in MRI are
bone marrow edema and soft tissue edema, joint effusion,
and eventually microfractures (subchondral) [2, 25]. Dur-
ing early stage of Charcot foot, there are no cortical frac-
tures and no gross deformity seen [26].
Fig. 11 Radiograph in dp projection showing the changes in foot
morphology in a typical Charcot foot patient over time (a baseline,
b 10 months later). Note the increase in forefoot abduction relative
to the hindfoot: The hindfoot-forefoot angle (yellow curve) is the
angle between the longitudinal axis of the 2nd metatarsal bone
(yellow line) and the bisection (black dotted line) of another
angle (white curve), which is formed by the following two lines: the
midline through the talar neck and head and a line parallel to the
lateral cortex of the calcaneus (white arrows) [19]
Fig. 12 Use of MRI for diabetic patients with neuropathy in the
setting of Charcot foot. Three main MRI-benefits: confirmation of
diagnosis in early Charcot, monitoring of disease activity, and
imaging of complications (infection/osteomyelitis)
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MRI of middle- to late-stage Charcot foot (frag
mentation to consolidation) Joint destruction, cortical
fractures, and joint dislocations are present (Figs. 15 and
16). Bone marrow edema can be present (very common
in middle-stage Charcot foot) or absent, depending on
disease activity. Especially the involvement of Lisfranc’s
joint leads to a typically superior and lateral dislocation
of the metatarsal bones leading to a complete collapse of
the longitudinal arch [2, 24, 25]. The talus head is typic-
ally tilted toward the sole of the foot (Fig. 17a), the na-
vicular bone typically dislocates into a medial and
superior position, often with fractures and fragmenta-
tion. Prominent well-marginated subchondral cysts are a
typical feature of the chronic Charcot foot (Fig. 17b).
Bone proliferation and sclerosis, debris, and intraarticular
Fig. 13 Proposed MRI-protocol for evaluation of the Charcot foot
with four sequences: sagittal STIR, 3 mm, whole foot (a); sagittal T1,
3 mm, whole foot (b); transverse T1, 3 mm, hindfoot including
Lisfranc’s joints (c); coronal T2, 3 mm, hindfoot including Lisfranc’s
joints (d). Additional contrast media application is optional for
patients with suspected infection/osteomyelitis: sagittal T1 fs 3 mm
post contrast and axial T1 fs 3 mm post contrast. Note: Of course,
the protocol should be extended and adapted in cases of non-
Charcot-related complications, that require better spatial resolutions:
e.g., additional sequences with smaller field of view, when infection
at the distal toes in a diabetic foot is suspected
Fig. 14 Imaging of early active Charcot foot. a Lateral weight-
bearing radiograph showing no abnormalities. b Sagittal STIR-
Sequence in MRI showing classic bone marrow edema in the
midfoot (black asterisks) and the soft tissue and muscle edema
(white arrows) in the midfoot
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bodies can occur (Fig. 17c) [2, 26]. Fluid collections sur-
rounding destructed joints may be huge (Fig. 18).
Monitoring of disease activity with MRI
MRI is the best imaging modality to monitor the disease
activity. As long as a significant amount of bone marrow
edema is seen on MRI, consequent off-loading therapy
with removable total contact casts has to be continued
[27]. After a significant decrease or complete disappear-
ance of bone marrow edema, the cast can be removed,
and an orthopedic shoe adapted (Fig. 19).
MR-imaging of complications: infection/osteomyelitis
In Charcot foot, the cuboid bone typically becomes the
most inferior bone in the foot [3] (Fig. 20). Due to the
resulting changes in pedal shape, the foot is prone to
extensive callus formation, blisters, and ulcerations, espe-
cially plantar to the cuboid bone (Fig. 20c). This may lead
to soft tissue infections and osteomyelitis (Fig. 20a, b) [2].
MRI has a high diagnostic accuracy in diagnosing
osteomyelitis of the foot, with a high sensitivity (77–
100%) and a high specificity (80–100%) [24]. MRI has a
very high negative predictive value (98%): if there are no
signs of osteomyelitis on MRI, osteomyelitis can practic-
ally be excluded [28].
Fig. 15 Active Charcot foot (stage of fragmentation). a Sagittal STIR:
note the superior dislocation of the metatarsals at the level of
Lisfranc’s joint (white arrow heads); massive bone marrow edema
(black asterisks) in metatarsal bone, navicular bone, and cuneiform
bones; and massive soft tissue edema (white thin arrows). b Sagittal
T1: shows degree of bone destruction and fragmentation in the
midfoot with huge signal drop (arrows) in the fatty bone marrow,
similar to signal drops in osteomyelitis (white arrows)
Fig. 16 Active middle-stage disease (fragmentation) of Charcot foot
demonstrating gross cortical fractures of the second to fifth
metatarsal bone (white arrows) (a coronal STIR image of the
forefoot, b corresponding oblique radiograph)
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However, discriminating an active Charcot foot from
acute osteomyelitis remains challenging [25]. Both
entities have similar image characteristics like bone mar-
row edema, soft tissue edema, joint effusions, fluid col-
lections, and contrast enhancement in bone marrow and
soft tissues. Even the degree of signal drop in T1 se-
quences might be quite similar in both conditions
(Figs. 15 and 20). However, there are some imaging fea-
tures (listed in Table 1, Fig. 21) that may help to find the
correct diagnosis.
Fig. 17 Three sagittal images of different patients showing classic
features of late-stage Charcot foot. a (Sagittal STIR) inferior
dislocation of the talar head (white arrow), effusion in the tibiotalar
joint (white arrow head). b (Sagittal STIR) prominent subchondral
cysts at the Lisfranc’s joint (white arrows). c (Sagittal T1) bone
proliferation and debris in the midfoot (white arrows) and
fragmentation of navicular bone
Fig. 18 A 45-year old patient with Charcot foot and sudden
shortening of the leg due to a collapse in Sanders/Frykberg zone IV
(a). Note the huge amount of fluid (black asterisk) and debris within
the impacted zone of the hindfoot (white arrows) on sagittal STIR-
image (b). Corresponding coronal CT slice in standing position (d)
shows medial dislocation of the hindfoot (red arrow) under weight-
bearing (d) compared to non-weight-bearing CT (c). The white
asterisk marks the calcaneus
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Advanced MR-imaging techniques
Diffusion-weighted imaging may contribute in the detec-
tion and extension of osteomyelitis: pure edema does not
show diffusion restriction, whereas the presence of pus
and inflammatory cells in infection leads to restricted dif-
fusion with lower ADC-values than in pure edema [31].
Dynamic contrast enhancement (DCE)-perfusion may
help in the discrimination between viable tissue and ne-
crosis. Furthermore, the enhancement pattern in DCE-
perfusion seems to be different between osteomyelitis and
osteoarthropathic changes, increasing the potential of dif-
ferencing lesions with bone marrow edema [30].
CT and nuclear medicine imaging
During early-stage Charcot foot, CT does not play an im-
portant role for imaging since bone marrow and soft tissue
Fig. 19 Before off-loading therapy (a sagittal STIR, b sagittal T1):
active stage of Charcot disease with a significant amount of bone
marrow edema (white arrow heads) and soft tissue edema (white
arrows) (a). Also note the subluxation at the Chopard’s joint with
downward tilt of the talar head (b) 7 months after a consequent off-
loading therapy with a total contact cast: note the almost complete
disappearance of bone marrow edema (white arrow heads) and soft
tissue edema on sagittal STIR sequence
Fig. 20 Patient with ulceration (a) at the sole of the foot directly
beneath the cuboid bone as a typical complication of rocker-bottom
deformity of the foot. MRI with sagittal STIR sequence (b)
demonstrates contiguous spread of infection from the skin, forming
a sinus tract (red arrow) to the cuboid bone (asterisk) and bone
marrow edema due to active Charcot disease (arrow heads). Sagittal
T1-weighted sequence shows focal replacement of fatty bone
marrow signal within the cuboid bone (c),
representing osteomyelitis
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changes can be better visualized using MRI [2]. However,
CT may be used in later-stage Charcot foot for better
visualization of bony proliferations and consolidation, or
for surgery planning and treatment monitoring in patients
with Ilizarov fixation [2]. Furthermore, CT and PET-CT
may be used as an alternative cross-section imaging tool in
patients with contraindications for MR examination (pace-
maker, severe claustrophobia, etc.). PET-CT allows the
quantification of the inflammatory process in all stages of
Charcot foot and allows to follow-up its evolution over
time: recent research showed that PET-CT may be of add-
itional help for evaluation of treatment duration in addition
to MR imaging [32].
Furthermore, nuclear medicine imaging may be of im-
portant value in non-conclusive cases with suspected in-
fection of a Charcot foot: a recent meta-analysis
compared MRI, FDG–PET-CT, and white blood cell
scintigraphy [33]. The authors concluded that despite all
of these modalities having a similar sensitivity for detec-
tion of osteomyelitis in Charcot foot, the nuclear im-
aging methods show a higher specificity [33]. However,
all nuclear medicine imaging methods are more expen-
sive than MRI and result in radiation exposure to the
patient.
Conclusion
The Charcot foot is a rare disease, associated with poly-
neuropathy, in industrialized countries most commonly
seen in the long-term diabetic population. The radiologist
plays an important role in the management of this disease.
Therefore, it is important to be familiar with the typical im-
aging characteristics of the Charcot foot and to consider
this diagnosis in a proper clinical setting. Recognizing this
disease in early stages prevents a delayed onset of an appro-
priate therapy and helps minimizing the disability of these
patients.
Although radiographs are important to assess the pos-
ition of the bones to each other in general, and in par-
ticular under load, MRI is the method of choice not only
in establishing an early diagnosis but also in monitoring
the course of the disease activity and in diagnosing in-
fectious complications.
Fig. 21 MRI of a Charcot foot complicated with osteomyelitis. a
Sagittal T1. b Sagittal STIR. c Sagittal T1 fat sat after contrast
administration. Skin ulceration and sinus tract extending from the
skin to the talar bone are present, showing a direct spread of
infection (red arrow) (a). Diffuse bone marrow alteration is present
within the talus. Note the disappearance of bony contours in the
sagittal T1-weighted image (white arrows in b) and the
reappearance of the bone structures after contrast administration
(white arrows in c) demonstrating the “Ghost sign,” which is
described in many reviews as pathognomonic for osteomyelitis in
Charcot foot [20]. However, up to now, there is no study published
evaluating the accuracy of this sign
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